Although the precise mechanisms through which these cells mediate resistance to anti-angiogenic therapy is not completely clear, they may promote the survival of tumour vessels and/or tumour cells through the secretion of growth factors such as BV8, in the case of immature myeloid cells [134], or PDGF-C, in the case of fibroblasts [141]. This evidence concerns the gene PROK2 and neoplasm.